The global Clinical Microbiology Market is witnessing steady growth, driven by factors such as the rise in infectious diseases, government subsidization of healthcare, and increasing research funding.
The rise of antibiotic resistance has renewed interest in bacteriophages as therapeutic alternatives. However, co-evolution of phage and bacteria will naturally give rise to phage-resistant pathogens, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback